Read your latest personalised notifications
Sign in
No account yet? Start here
Don't miss out
Ok, got it
The EAPC Board and Research Committee is pleased to present the fourth Vivane Conraads Award to Professor Emanuele Di Angelantonio (Cambridge, UK) for his achievements and significant contribution to the improvement of healthcare in relation to cardiovascular disease prevention.
This award was established to recognise the contribution of Viviane Conraads, who was head of the Heart Failure Clinic of the University Hospital of Antwerp, and responsible for cardiac rehabilitation and the heart transplant program.
She played a very important role in the EAPC as a nucleus member of the Exercise, Basic and Translational Research section and as the EAPC representative in the Congress Programme Committee.
Professor Di Angelantonio has contributed significantly to improvements in healthcare related to prevention of cardiovascular diseases (CVD), and his work has helped resolve important clinical and public health controversies through its combination of powerful, systematic, and detailed analysis of prospective epidemiological data on CVD risk factors.
Read more
Dr Trine Moholdt is physiotherapeut and PhD. She works as a research fellow at the Department of Circulation and Medical Imaging, Norwegian University of Science and Technology (NTNU) in Trondheim, Norway. Dr Moholdt has contributed to the field of exercise as medicine in primary and secondary prevention of cardiovascular disease.
Professor Sundström is Professor of Epidemiology at Uppsala University, Scientific Director of Uppsala Clinical Research Center (UCR), and works clinically at the Department of Cardiology of Uppsala University Hospital.
Professor Sharma is Professor of Inherited Cardiac Diseases and Sports Cardiology and Head of Cardiac Research Center, St George’s University of London since 2010. His academic interests include Sports Cardiology, Cardiomyopathies, Ion channel disease and Exercise Physiology.
For more information, contact the EAPC team.
Our mission: To reduce the burden of cardiovascular disease
